Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-20 · accession 0001193125-26-017942 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-01-21 | 2026-01-20 | BEAM | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $30.12 | -3,034 | 41.0K | -7% | -$91.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | S | D | 3,034 | $30.12 | 41,011 | D | — | — |